Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge.

Molecular therapy : the journal of the American Society of Gene Therapy·2010
Same author

Modeling performance of a two-dimensional capsule in a microchannel flow: long-term lateral migration.

Physical review. E, Statistical, nonlinear, and soft matter physics·2010
Same author

Neuroprotective effects of resveratrol on ischemic injury mediated by improving brain energy metabolism and alleviating oxidative stress in rats.

Neuropharmacology·2010
Same author

[Determination of prim-O-glucosylcimifugin and 5-O-methylvisammisoide in Saposhnikovia divaricata and HPLC fingerprint analysis].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2010
Same author

Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus.

Neuroscience letters·2010
Same author

Design, synthesis and activity of benzothiazole-based inhibitors of NO production in LPS-activated macrophages.

Bioorganic & medicinal chemistry letters·2010

Related Experiment Video

Updated: Jun 14, 2026

A Pre-clinical Rat Model for the Study of Ischemia-reperfusion Injury in Reconstructive Microsurgery
08:05

A Pre-clinical Rat Model for the Study of Ischemia-reperfusion Injury in Reconstructive Microsurgery

Published on: November 8, 2019

Mimic hypoxia improves angiogenesis in ischaemic random flaps.

Rui Weng1, Qingfeng Li, Hua Li

  • 1Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai 200011, PR China.

Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|April 3, 2010
PubMed
Summary

Deferoxamine (DFO) treatment significantly improved survival rates and blood vessel density in ischemic skin flaps by mimicking hypoxia. This approach enhances vascular endothelial growth factor (VEGF) secretion, promoting angiogenesis and protecting cells from hypoxic injury.

More Related Videos

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

The Superficial Inferior Epigastric Artery Axial Flap to Study Ischemic Preconditioning Effects in a Rat Model
09:07

The Superficial Inferior Epigastric Artery Axial Flap to Study Ischemic Preconditioning Effects in a Rat Model

Published on: January 27, 2023

Related Experiment Videos

Last Updated: Jun 14, 2026

A Pre-clinical Rat Model for the Study of Ischemia-reperfusion Injury in Reconstructive Microsurgery
08:05

A Pre-clinical Rat Model for the Study of Ischemia-reperfusion Injury in Reconstructive Microsurgery

Published on: November 8, 2019

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

The Superficial Inferior Epigastric Artery Axial Flap to Study Ischemic Preconditioning Effects in a Rat Model
09:07

The Superficial Inferior Epigastric Artery Axial Flap to Study Ischemic Preconditioning Effects in a Rat Model

Published on: January 27, 2023

Area of Science:

  • Regenerative Medicine
  • Tissue Engineering
  • Vascular Biology

Background:

  • Hypoxia is a critical signal for angiogenesis in ischemic tissues.
  • Hypoxia-induced angiogenesis often fails to prevent tissue necrosis after surgery.
  • Mimicking hypoxia presents a potential strategy to enhance angiogenesis and reduce necrosis.

Purpose of the Study:

  • To investigate the efficacy of deferoxamine (DFO), a hypoxia mimic, in treating ischemic random skin flaps.
  • To evaluate DFO's impact on angiogenesis and flap survival.

Main Methods:

  • Ischemic random skin flap models were established in mice (n=18).
  • Groups included DFO-treated and control.
  • Evaluated VEGF levels, vessel density, and flap survival rate.
  • In vitro studies assessed VEGF expression and cell viability under DFO, hypoxia, and normoxia.

Main Results:

  • DFO treatment significantly increased flap survival rate, vessel density, and VEGF levels compared to controls.
  • In vitro, DFO increased VEGF mRNA and protein secretion in endothelial cells and fibroblasts.
  • DFO-induced VEGF secretion enhanced endothelial cell viability after hypoxic injury.

Conclusions:

  • DFO-induced angiogenesis, mediated by VEGF paracrine and autocrine signaling, improves ischemic flap survival.
  • DFO-induced VEGF autocrine secretion protects endothelial cells from severe hypoxia.